Skip to main content
. 2021 Apr 26;16(4):e0250628. doi: 10.1371/journal.pone.0250628

Table 1. Survival from sample collection in MPE cohorts.

Cohort descriptor n Survival from sample date Median (IQR) days
All—Malignant Pleural Effusion 117 284 (92–620)
 MM 65 396 (216–814)
 Other cancers 52 126 (39–334)
  Lung cancer 24 121 (39–284)
  Breast cancer 8 167 (75–475)

MM, malignant mesothelioma; IQR, interquartile range.